RO4998452
Sponsors
Hoffmann-La Roche
Conditions
Diabetes Mellitus Type 2
Phase 1
A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus.
CompletedNCT00682097
Start: 2008-05-31End: 2009-03-31Updated: 2016-11-02
A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal Impairment
CompletedNCT00933972
Start: 2009-06-30End: 2010-09-30Updated: 2016-11-02
A Study of Single Doses of RO4998452 in Patients With Type 2 Diabetes
CompletedNCT01044017
Start: 2009-12-31End: 2010-08-31Updated: 2016-11-02